ipsas 29—financial instruments: recognition and measurement - IFAC
ipsas 29—financial instruments: recognition and measurement - IFAC
ipsas 29—financial instruments: recognition and measurement - IFAC
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
FINANCIAL INSTRUMENTS: RECOGNITION AND MEASUREMENT<br />
TOTAL (for the internal derivatives) A B Total<br />
LC LC TC<br />
Surplus or deficit (fair value hedges) 10 (5) 5<br />
Net assets/equity (cash flow hedges) 20 – 20<br />
Basis adjustment (inventory) – (50) (50)<br />
Total 30 (55) (25)<br />
Combining these amounts with the external transactions (i.e., those not marked in<br />
italics above) produces the total net balances before elimination of the internal<br />
derivatives as follows:<br />
IPSAS 29 IMPLEMENTATION GUIDANCE 1208<br />
Debit Credit<br />
Receivables – LC10<br />
Payables LC5 –<br />
Forward contract – LC25<br />
Net assets/equity – LC20<br />
Basis adjustment (inventory) LC50 –<br />
Gains <strong>and</strong> losses – –<br />
Internal contracts – –<br />
For the consolidated financial statements, the following designations are made at the<br />
beginning of month 1:<br />
• The payable of FC50 in B is designated as a hedge of the first FC50 of the<br />
highly probable future revenues in A. Therefore, at the end of month 1, the<br />
following entry is made in the consolidated financial statements: Dr Payables<br />
LC5; Cr Net assets/equity LC5.<br />
• The receivable of FC100 in A is designated as a hedge of the first FC100 of<br />
the highly probable future expenses in B. Therefore, at the end of month 1, the<br />
following entries are made in the consolidated financial statements: Dr Net<br />
assets/equity LC10; Cr Receivable LC10; <strong>and</strong> at the end of month 2, Dr<br />
Inventory LC10; Cr Net assets/equity LC10.<br />
• The external forward contract on FC250 in TC is designated as a hedge of the<br />
next FC250 of highly probable future expenses in B. Therefore, at the end of<br />
month 1, the following entry is made in the consolidated financial statements:<br />
Dr Net assets/equity LC25; Cr External forward contract LC25; <strong>and</strong> at the end<br />
of month 2, Dr Inventory LC25; Cr Net assets/equity LC25.<br />
The total net balances after elimination of the accounting entries relating to the internal<br />
derivatives are as follows: